Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/222330 |
Resumo: | OBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened. |
id |
USP-23_8ef2952568d47b6dca08b6e0fe1c8a45 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/222330 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth CohortContraceptive AgentsContraindicationsProgesteroneContraceptives, Oral, CombinedIntrauterine DevicesOBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened.Universidade de São Paulo. Faculdade de Saúde Pública2024-02-21info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/xmlapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/22233010.11606/s1518-8787.2024058005585Revista de Saúde Pública; v. 58 n. 1 (2024); 2Revista de Saúde Pública; Vol. 58 Núm. 1 (2024); 2Revista de Saúde Pública; Vol. 58 No. 1 (2024); 21518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/222330/202989https://www.revistas.usp.br/rsp/article/view/222330/202990Copyright (c) 2024 Gbènankpon Mathias Houvèssou, Simone Farías-Antúnez, Andréa D. Bertoldi, Mariângela Freitas da Silveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas daHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas daHouvèssou, Gbènankpon MathiasFarías-Antúnez, SimoneBertoldi, Andréa D.Silveira, Mariângela Freitas da2024-04-30T18:42:01Zoai:revistas.usp.br:article/222330Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2024-04-30T18:42:01Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
title |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
spellingShingle |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort Houvèssou, Gbènankpon Mathias Contraceptive Agents Contraindications Progesterone Contraceptives, Oral, Combined Intrauterine Devices |
title_short |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
title_full |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
title_fullStr |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
title_full_unstemmed |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
title_sort |
Contraindicated use of modern contraceptives among mothers from a Pelotas Birth Cohort |
author |
Houvèssou, Gbènankpon Mathias |
author_facet |
Houvèssou, Gbènankpon Mathias Farías-Antúnez, Simone Bertoldi, Andréa D. Silveira, Mariângela Freitas da |
author_role |
author |
author2 |
Farías-Antúnez, Simone Bertoldi, Andréa D. Silveira, Mariângela Freitas da |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Houvèssou, Gbènankpon Mathias Farías-Antúnez, Simone Bertoldi, Andréa D. Silveira, Mariângela Freitas da Houvèssou, Gbènankpon Mathias Farías-Antúnez, Simone Bertoldi, Andréa D. Silveira, Mariângela Freitas da Houvèssou, Gbènankpon Mathias Farías-Antúnez, Simone Bertoldi, Andréa D. Silveira, Mariângela Freitas da |
dc.subject.por.fl_str_mv |
Contraceptive Agents Contraindications Progesterone Contraceptives, Oral, Combined Intrauterine Devices |
topic |
Contraceptive Agents Contraindications Progesterone Contraceptives, Oral, Combined Intrauterine Devices |
description |
OBJECTIVE: To describe the prevalence of contraindicated use of combined hormonal contraceptives, progesterone-only contraceptives, and intrauterine devices in mothers participating in the 2015 Pelotas Birth Cohort according to the WHO medical eligibility criteria. METHODS: The biological mothers of children belonging to the 2015 Pelotas birth cohort who attended the 48-month follow-up were studied. The 48-month follow-up data were collected from January 1, 2019, to December 31, 2019. Contraindicated use of modern contraceptives was considered to occur when these women presented at least one of the contraindications for the use of modern contraceptives and were using these methods. The prevalence of contraindicated use was calculated according to each independent variable and their respective 95% confidence intervals (95%CI). RESULTS: The analyzed sample consisted of 3,053 women who used any modern contraceptive method. The prevalence of contraindicated use of modern contraceptives totaled 25.9% (95%CI: 24.4–27.5). Combined hormonal contraceptives showed the highest prevalence of contraindicated use (52.1%; 95%CI: 49.3–54.8). The prevalence of contraindicated use of modern contraceptives methods was greater in women with family income between one and three minimum wages, a 25–30 kg/m2 body mass index, indication by a gynecologist for the used method, and purchasing the contraceptive method at a pharmacy. The higher the women’s education, the lower the prevalence of inappropriate use of modern contraceptives. CONCLUSION: In total, one in four women used modern contraceptives despite showing at least one contraindication. Policies regarding women’s reproductive health should be strengthened. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-02-21 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/222330 10.11606/s1518-8787.2024058005585 |
url |
https://www.revistas.usp.br/rsp/article/view/222330 |
identifier_str_mv |
10.11606/s1518-8787.2024058005585 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/222330/202989 https://www.revistas.usp.br/rsp/article/view/222330/202990 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/xml application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; v. 58 n. 1 (2024); 2 Revista de Saúde Pública; Vol. 58 Núm. 1 (2024); 2 Revista de Saúde Pública; Vol. 58 No. 1 (2024); 2 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221766385139712 |